Skip to content

A randomized controlled trial for Zhongfeng Xingnaoyie decoction in the treatment of Acute Cerebral Infarction

Clinical Evidence-based Evaluation of Traditional Chinese Medicine for Acute Cerebral Infarction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004506
Enrollment
Unknown
Registered
2021-02-28
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Interventions

control group:Basic treatment

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40-80 years old; 2. Meet the diagnostic criteria for acute cerebral infarction. 3. Onset time of acute cerebral infarction is less than 7 days. 4. NIHSS score >= 6 points. 5. The family members or I signed the written informed consent to participate in this trial. Those who meet the above 5 items can be included in the study.

Exclusion criteria

Exclusion criteria: 1. It is confirmed by examination that cerebral infarction is caused by brain tumors and vascular malformations; 2. Patients with thrombolysis and emergency interventional thrombolysis and thrombectomy; 3. Patients who died within 24 hours of admission; 4. Accompanied by severe heart disease, cardiac insufficiency, liver dysfunction, renal insufficiency, respiratory failure, malignant tumor, gastrointestinal bleeding, etc.; 5. Mentally ill patients; 6. Those who are participating in other clinical trials.

Design outcomes

Secondary

MeasureTime frame
modified Rankin scale ; the Barthelindex of ADL ;Glasgow Score;

Primary

MeasureTime frame
National Institute of Health stroke scale;

Countries

China

Contacts

Public ContactXiaoyun Zhang

Chengdu University of Traditional Chinese Medicine

zhangxy1980@126.com+86 18980880120

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026